This article evaluates a novel single-photon emission computed tomography/computed tomography (VQ SPECT/CT)-derived Ventilation Perfusion Capacity Differential Index (VQCDI) for predicting post-treatment lung function in early-stage lung cancer.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Lung cancer
February 26, 2026
February 23, 2026
This video demonstrates a robotic S8 segmentectomy for a deep pulmonary metastasis uniquely guided by high-resolution 3D reconstruction imaging.
February 19, 2026
This video demonstrates a right uniportal video-assisted thoracoscopic surgery and right upper lobe sleeve lobectomy for a case of synchronous right upper lobe carcinoid tumor and lung adenocarcinoma.
February 12, 2026
This study investigated whether antifibrotic therapy is associated with a reduced incidence of lung cancer in patients with idiopathic pulmonary fibrosis (IPF).
February 5, 2026
In this nationwide retrospective cohort study, the authors evaluated outcomes of minimally invasive lobectomy (MIL) vs stereotactic ablative radiotherapy (SABR) in 2,183 patients with stage I non-small cell lung cancer (NSCLC) treated between 2014 and 2016. After propensity score weighting, overall survival differed by clinical subgroups.
January 15, 2026
In this fascinating interview, CTSNet Editor-in-Chief Joel Dunning spoke with Drs. Michael Lanuti and thoracic surgeon and Leanne Ashrafian about Dr. Lanuti’s thoughts on the JCOG0802 trial and how he believes the wrong parameters were measured.
January 13, 2026
This video depicts a minimally invasive sleeve resection of centrally located mucoepidermoid carcinoma in the right lower lobe, followed by complex airway reconstruction.
January 8, 2026
In this remarkable interview, CTSNet Editor-in-Chief Joel Dunning and CTSNet Senior Editor Leanne Ashrafian spoke with Dr. Gavin Wright about his thoughts on the JCOG0802 trial and why he prefers segmentectomy over lobectomy.
January 8, 2026
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Dr. Gavin Wright and CTSNet Senior Editor Leanne Ashrafian about Dr. Wright’s thoughts on the JCOG0802 trial and why he prefers segmentectomy over lobectomy.
December 23, 2025
In this study, the authors report the long-term outcomes of the randomized phase II NEOpredict-Lung trial, which evaluates short-course neoadjuvant nivolumab with or without the LAG-3 inhibitor relatlimab in resectable non-small cell lung cancer (NSCLC).